Please login to the form below

Not currently logged in
Email:
Password:

Edelman launches integrated marketing unit

Public relations firm Edelman is launching an integrated marketing unit to provide cross-channel strategy and content to its clients

The independent public relations firm Edelman is launching an integrated marketing unit to provide cross-channel strategy and content to its clients. The division, which is called Ruth after Edelman founder and chairman Dan Edelman's wife, counts Pfizer among its initial clients but is equipped to work with companies from all industries and with varied budgets, according to the PR firm.

The unit "combines long-standing in-house speciality creative teams with new creative talent and account managers recruited from the integrated marketing, brand, and advertising industries," the company explained. Offerings include brand and visual identity, editorial, graphic design, direct-to-consumer advertising, event production and mobile marketing, and play-anywhere content.

Edelman said Ruth was launched in part to help the PR firm compete with boutique agencies. The unit is headed up by Matthew J Harrington, president and CEO of Edelman US, and has regional hubs in New York, Seattle, Chicago, and Washington DC staffed by more than 70 creative directors, art directors and designers, writers, producers and event specialists, as well as account directors and senior strategists.

Ruth joins other existing speciality businesses at the company, including the reputation and issues advocacy unit Blue; the sports and entertainment marketing unit MATTER; the research services unit StrategyOne; and DJE Sciences, which focuses on scientific communications.

5th October 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics